Your browser doesn't support javascript.
loading
Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study).
Groth, Kristian A; Stochholm, Kirstine; Hove, Hanne; Andersen, Niels H; Gravholt, Claus H.
Afiliación
  • Groth KA; Department of Cardiology, Aarhus University Hospital, Aarhus,Denmark; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: kristian.groth@clin.au.dk.
  • Stochholm K; Centre for Rare Diseases, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus,Denmark.
  • Hove H; Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark; The RAREDIS Database, Section of Rare Diseases, Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
  • Andersen NH; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Gravholt CH; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus,Denmark.
Am J Cardiol ; 122(7): 1231-1235, 2018 10 01.
Article en En | MEDLINE | ID: mdl-30149886
ABSTRACT
The Marfan syndrome (MFS) is strongly associated with aortic disease causing a high prevalence of prophylactic aortic surgery, aortic dissection, and sudden death. The aim of the present study was to evaluate mortality in a nationwide Danish MFS population diagnosed by the Ghent II criteria. In a register-based setting, we identified all Danish patients with MFS (n = 412, men n = 215) by assessment of their medical records. We established a gender and age matched control cohort based on 41,000 control patients (men n = 21,500). MFS cases risk time was 6,669 patient years. We applied Cox regression using each case and his/her control as one stratum, adjusting for age and calendar time. We found a significantly decreased lifespan of 50years compared with 60years among controls. The mortality hazard ratio among MFS compared with controls was significantly increased to3.6 (CI 2.8-4.7, p < 0.001); men 4.0 (CI 2.8-5.7, p < 0.001); women 3.2 (CI 2.1-4.8,p < 0.001). Aorta disease represented the main reason for the overall increased mortality with a hazard ratio of 194.6 (CI 67.4-561.7, p < 0.0001); men 208.7 (CI 53.8-809.1, p < 0.001); women 173.4 (CI 31.5-954.5, p < 0.001). In addition, an unexplained mortality due to respiratory illness was not attributed to pneumothorax. Excluding cardiovascular and respiratory causes of death, we found no indication that MFS is associated with increased mortality for other reasons.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades de la Aorta / Síndrome de Marfan Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Am J Cardiol Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades de la Aorta / Síndrome de Marfan Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Am J Cardiol Año: 2018 Tipo del documento: Article